Abstract 15749: Sex-differences in Coronary Heart Disease Between Individuals With Familial Hypercholesterolemia and Controls in Norway During 1992-2017
IntroductionDuring the last 30 years, treatment of familial hypercholesterolemia (FH) has been revolutionized, but it is not known if both sexes equally benefit in these advances, and whether this could have affected the sex difference in risk of coronary heart disease (CHD). We aimed to study sex d...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 142; no. Suppl_3 Suppl 3; p. A15749 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
by the American College of Cardiology Foundation and the American Heart Association, Inc
17.11.2020
|
Online Access | Get full text |
Cover
Loading…
Abstract | IntroductionDuring the last 30 years, treatment of familial hypercholesterolemia (FH) has been revolutionized, but it is not known if both sexes equally benefit in these advances, and whether this could have affected the sex difference in risk of coronary heart disease (CHD). We aimed to study sex difference in the risk of CHD between men and women with FH compared to non-FH men and women.MethodsWe obtained data on CHD hospitalization and death from Norwegian health registries in 4,525 individuals diagnosed with FH between 1992 and 2014 and an age and sex matched control population of 88,892. The sex distribution was about 50/50 between women and men, and the mean age at start of follow-up was 36 years.ResultsThe cumulative incidence of CHD (FH vs. non-FH controls) in women and men are shown in Figure 1 with a clear increased risk in FH compared to controls. The cumulative incidence starts to increase at a younger age in men compared with women, both in FH and non-FH controls. This corresponds to an age adjusted 2.6-fold higher risk of CHD in men compared with women in both the FH and control population. In the FH population, men aged 20-39 years had a hazard ratio (HR) of 5.3 (95% CI2.6-10.9) compared with women, whereas the corresponding HR between women and men in non-FH controls was 3.7 (95% CI2.6-5.3). There was no significant interaction between sex and FH status, indicating that the excess risk in men was similar in FH and non-FH controls. Stratified by sex and adjusted for age, we found that both men and women with FH had a 2-fold higher risk of CHD than controls. The highest excess risk was observed in ages 20-30 years with a of HR= 4.5 (95% CI2.2-9.2) and a HR of= 5.5 (95%CI4.60-9.34) in women and men, respectively.ConclusionsThe risk of CHD among individuals with FH was higher in men than in women in all age groups presented, with no differences between the FH sample and the non-FH controls. However, the relative risk in FH compared with controls was similar for both sexes. |
---|---|
AbstractList | IntroductionDuring the last 30 years, treatment of familial hypercholesterolemia (FH) has been revolutionized, but it is not known if both sexes equally benefit in these advances, and whether this could have affected the sex difference in risk of coronary heart disease (CHD). We aimed to study sex difference in the risk of CHD between men and women with FH compared to non-FH men and women.MethodsWe obtained data on CHD hospitalization and death from Norwegian health registries in 4,525 individuals diagnosed with FH between 1992 and 2014 and an age and sex matched control population of 88,892. The sex distribution was about 50/50 between women and men, and the mean age at start of follow-up was 36 years.ResultsThe cumulative incidence of CHD (FH vs. non-FH controls) in women and men are shown in Figure 1 with a clear increased risk in FH compared to controls. The cumulative incidence starts to increase at a younger age in men compared with women, both in FH and non-FH controls. This corresponds to an age adjusted 2.6-fold higher risk of CHD in men compared with women in both the FH and control population. In the FH population, men aged 20-39 years had a hazard ratio (HR) of 5.3 (95% CI2.6-10.9) compared with women, whereas the corresponding HR between women and men in non-FH controls was 3.7 (95% CI2.6-5.3). There was no significant interaction between sex and FH status, indicating that the excess risk in men was similar in FH and non-FH controls. Stratified by sex and adjusted for age, we found that both men and women with FH had a 2-fold higher risk of CHD than controls. The highest excess risk was observed in ages 20-30 years with a of HR= 4.5 (95% CI2.2-9.2) and a HR of= 5.5 (95%CI4.60-9.34) in women and men, respectively.ConclusionsThe risk of CHD among individuals with FH was higher in men than in women in all age groups presented, with no differences between the FH sample and the non-FH controls. However, the relative risk in FH compared with controls was similar for both sexes. Abstract only Introduction: During the last 30 years, treatment of familial hypercholesterolemia (FH) has been revolutionized, but it is not known if both sexes equally benefit in these advances, and whether this could have affected the sex difference in risk of coronary heart disease (CHD). We aimed to study sex difference in the risk of CHD between men and women with FH compared to non-FH men and women. Methods: We obtained data on CHD hospitalization and death from Norwegian health registries in 4,525 individuals diagnosed with FH between 1992 and 2014 and an age and sex matched control population of 88,892. The sex distribution was about 50/50 between women and men, and the mean age at start of follow-up was 36 years. Results: The cumulative incidence of CHD (FH vs. non-FH controls) in women and men are shown in Figure 1 with a clear increased risk in FH compared to controls. The cumulative incidence starts to increase at a younger age in men compared with women, both in FH and non-FH controls. This corresponds to an age adjusted 2.6-fold higher risk of CHD in men compared with women in both the FH and control population. In the FH population, men aged 20-39 years had a hazard ratio (HR) of 5.3 (95% CI: 2.6-10.9) compared with women, whereas the corresponding HR between women and men in non-FH controls was 3.7 (95% CI: 2.6-5.3). There was no significant interaction between sex and FH status, indicating that the excess risk in men was similar in FH and non-FH controls. Stratified by sex and adjusted for age, we found that both men and women with FH had a 2-fold higher risk of CHD than controls. The highest excess risk was observed in ages 20-30 years with a of HR= 4.5 (95% CI: 2.2-9.2) and a HR of= 5.5 (95%CI: 4.60-9.34) in women and men, respectively. Conclusions: The risk of CHD among individuals with FH was higher in men than in women in all age groups presented, with no differences between the FH sample and the non-FH controls. However, the relative risk in FH compared with controls was similar for both sexes. |
Author | Holven, Kirsten B Krogh, Henriette W Bogsrud, Martin P Tell, Grethe S Leren, Trond P Retterstol, Kjetil Igland, Jannicke Svendsen, Karianne Mundal, Liv J |
AuthorAffiliation | UNIVERSITY OF OSLO, Oslo, Norway Global Public Health and Primary Care, Univ of Bergen, Bergen, Norway Nutrition, UNIVERSITY OF OSLO, Oslo, Norway Oslo Univ Hosp, Oslo, Norway |
AuthorAffiliation_xml | – name: UNIVERSITY OF OSLO, Oslo, Norway Global Public Health and Primary Care, Univ of Bergen, Bergen, Norway Nutrition, UNIVERSITY OF OSLO, Oslo, Norway Oslo Univ Hosp, Oslo, Norway |
Author_xml | – sequence: 1 givenname: Karianne surname: Svendsen fullname: Svendsen, Karianne organization: UNIVERSITY OF OSLO, Oslo, Norway Global Public Health and Primary Care, Univ of Bergen, Bergen, Norway Nutrition, UNIVERSITY OF OSLO, Oslo, Norway Oslo Univ Hosp, Oslo, Norway – sequence: 2 givenname: Jannicke surname: Igland fullname: Igland, Jannicke – sequence: 3 givenname: Henriette surname: Krogh middlename: W fullname: Krogh, Henriette W – sequence: 4 givenname: Grethe surname: Tell middlename: S fullname: Tell, Grethe S – sequence: 5 givenname: Liv surname: Mundal middlename: J fullname: Mundal, Liv J – sequence: 6 givenname: Kirsten surname: Holven middlename: B fullname: Holven, Kirsten B – sequence: 7 givenname: Martin surname: Bogsrud middlename: P fullname: Bogsrud, Martin P – sequence: 8 givenname: Trond surname: Leren middlename: P fullname: Leren, Trond P – sequence: 9 givenname: Kjetil surname: Retterstol fullname: Retterstol, Kjetil |
BookMark | eNotkM1OAjEYRRuDiaC-gukLDPZn2s64UxAhMbrQxGVT2m-kOnRIO4i8iY9rQVc3d3Fvcs4IDUIXAKErSsaUSnptfbRjWrJx2m42reZjKlRZn6AhFawsSsHrARoSQupCccbO0Cilj1wlV2KIfm6XqY_G9vi4usEv8F043zQQIVhI2Ac86WIXTNzjOZjY46lPYBLgO-h3AAEvgvNf3m1Nm_Cb71d4Zta-9abF8_0Gol11LaQeYo61N9gElx9Dn_vx_amLO7PH02304R3TumYFI1RdoNMmP8Llf56j19n962RePD4_LCa3j4WtGS-EsFyBqaQVrgSqZGMUraUERxyTvJJUNc4J0qjKglkK45ZG1YxYVwmiHOfnSP7d2tilFKHRm-jXGVZTog969UGvznr1v159FJWH5d9w17UZLn222x1EvQLT9iud_RKeKTJKhqFU8YLQinH-C9jrhCU |
ContentType | Journal Article |
Copyright | 2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. |
Copyright_xml | – notice: 2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. |
DBID | AAYXX CITATION |
DOI | 10.1161/circ.142.suppl_3.15749 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1524-4539 |
EndPage | A15749 |
ExternalDocumentID | 10_1161_circ_142_suppl_3_15749 00003017-202011173-01823 |
GroupedDBID | - .XZ .Z2 01R 0R 1AW 1J1 29B 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O 7O~ 8RP AAAXR AAMOA AAMTA AAPBV AARTV AAWTL AAXQO ABBUW ABFLS ABOCM ABPMR ABPTK ABUFD ABXVJ ABZAD ACDDN ACEWG ACGFS ACRKK ACWDW ACWRI ACXNZ ADBBV ADCYY AENEX AFCHL AFUWQ AHMBA AHULI AHVBC AIJEX AJIOK ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII ASPBG AVWKF AWKKM AZFZN BAWUL BOYCO BQLVK BYPQX C45 CS3 DIK DU5 E.X E3Z EBS EX3 F2K F2L F2M F2N F5P FL- H0 H0~ H1 HZ IKYAY IN IN~ JF9 JG8 JK3 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O0- O9- OAG OAH OBH OCB ODA OGEVE OHASI OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWW OWY OXXIT P2P PQEST PQQKQ RAH RHF RIG RLZ S4R S4S UPT V2I W2D WH7 WOQ WOW X3V X3W XZ YZZ Z2 ZA5 ZY1 ~H1 --- .-D .3C 0R~ 0ZK 18M 2FS 2WC 354 6PF AAAAV AAGIX AAHPQ AAIQE AAJCS AAQKA AASCR AASOK AASXQ AAUEB AAYXX ABASU ABDIG ABJNI ABQRW ABVCZ ACGFO ACILI ACOAL ACXJB ADGGA ADHPY AE3 AE6 AEBDS AFDTB AFEXH AFSOK AGINI AHOMT AHQNM AHRYX AINUH AJNWD AJZMW AKULP ALMTX AMKUR AMNEI AOHHW AYCSE CITATION DIWNM EEVPB ERAAH FCALG GNXGY GQDEL GX1 HLJTE HZ~ IKREB IPNFZ K-A K-F ODMTH OHH OHYEH OJAPA OLB OWBYB OWU OWV OWX OWZ T8P TEORI TR2 TSPGW VVN W3M W8F XXN XYM YFH YOC YSK YYM ZFV |
ID | FETCH-LOGICAL-c923-55c37ea86c5d4e176fa71966ed0d2638617fdd50f78ceab5adba7920cd8507d33 |
ISSN | 0009-7322 |
IngestDate | Fri Aug 23 00:53:15 EDT 2024 Thu Nov 26 03:31:37 EST 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl_3 Suppl 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c923-55c37ea86c5d4e176fa71966ed0d2638617fdd50f78ceab5adba7920cd8507d33 |
ParticipantIDs | crossref_primary_10_1161_circ_142_suppl_3_15749 wolterskluwer_health_00003017-202011173-01823 |
ProviderPackageCode | OVOZU L-C C45 7O~ AARTV ABPMR OLH ASCII BYPQX OLG AAMOA ODA ABZAD ABBUW JK3 H0~ 1J1 OLV OLU JG8 OLW OLZ OLY F2K F2M F2L F2N OHASI AHVBC FL- KMI OGEVE K8S OVLEI AJIOK OPUJH V2I .XZ S4R S4S 4Q1 OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI ACEWG .Z2 N~7 IKYAY OVIDH AWKKM 40H N~B OBH X3V X3W ACDDN ACWRI BOYCO AIJEX AAXQO ~H1 AAMTA AAAXR E.X OWW OCB OWY 01R ACXNZ OL1 AFCHL ABXVJ IN~ KD2 OXXIT 77Y ACWDW JF9 |
PublicationCentury | 2000 |
PublicationDate | 2020-November-17 2020-11-17 |
PublicationDateYYYYMMDD | 2020-11-17 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-November-17 day: 17 |
PublicationDecade | 2020 |
PublicationTitle | Circulation (New York, N.Y.) |
PublicationYear | 2020 |
Publisher | by the American College of Cardiology Foundation and the American Heart Association, Inc |
Publisher_xml | – name: by the American College of Cardiology Foundation and the American Heart Association, Inc |
SSID | ssj0006375 |
Score | 2.3948276 |
Snippet | IntroductionDuring the last 30 years, treatment of familial hypercholesterolemia (FH) has been revolutionized, but it is not known if both sexes equally... Abstract only Introduction: During the last 30 years, treatment of familial hypercholesterolemia (FH) has been revolutionized, but it is not known if both... |
SourceID | crossref wolterskluwer |
SourceType | Aggregation Database Publisher |
StartPage | A15749 |
Title | Abstract 15749: Sex-differences in Coronary Heart Disease Between Individuals With Familial Hypercholesterolemia and Controls in Norway During 1992-2017 |
URI | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-202011173-01823 |
Volume | 142 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKkBASQrCBGF_yA-KlcpcvxwlvZcC6oe1lRepblNjOqNASFDLG-CX8Mn4P99pOmk4VYrykVdTetLknvr7X5_gS8iqRsRaFCFmpfcWiIk9ZEXLNSqnzIlYq9I2-4vgknn2KjhZ8MRr9HrCWLtpiIn9u1JX8j1fhHPgVVbI38GxvFE7Ae_AvHMHDcPwnH08LLFTIduxzEaWY3J_qH6zreWK5VvDEN7XR3M4A1C1ut4krMuO3jqB12CuykArbfratMLCOPoMUtcHR0WymAC_nVsCFKkGktxvrJ3VzmV-N31m1o2GZQrAXwznv_rKRrknYpt4_g1rE6Xck6NqB8CMk8Xm1WvQ_POs4mEfYZgkGnz5WNLVdKELBxRKpS-O-cDR3yyoHDQqbXZ3XFTkgo0WinVgbuFMmQithnmg3VgcRi7jdC6kfzKNggFrTGTULN4eKGEOFhFsA0SKAUGU-OjEOWwXHjhBwLWb2TEaTQ8V-hnYgjQoyZyczdm6R24FIORYFDhYr6lEcCt51-MM_5ZTrYGdv8-9ZmzTdu6yRSPHti9FRDGZD8wfkvktj6NRi8iEZ6Wqb7EyrvK3Pr-hraojFZsVmm9w5dvyNHfKrQyw1F3xDr-GVLiva4ZUavFKHV-rwSgd4pYhX2uGVbsIrBczQDq9o3eKVWrzSHq-PyPzD-_n-jLneIExCSsI4l6HQeRJLriLti7jMBcSSWCtPBRBSYF5eKsW9UiQ46PBcFblIA0-qBBIgFYaPyVZVV_oJoamMhEjyyFdeFMGXUp4UYZKUSeqlng7SXbLX3fvsq90BJvu713cJW3NRZiXNyPPAAoRgiHCYYwhkMiZB-PTGV3hG7q6ekudkq20u9AuYHLfFS4O0P5AiuyU |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+15749%3A+Sex-differences+in+Coronary+Heart+Disease+Between+Individuals+With+Familial+Hypercholesterolemia+and+Controls+in+Norway+During+1992-2017&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Svendsen%2C+Karianne&rft.au=Igland%2C+Jannicke&rft.au=Krogh%2C+Henriette+W&rft.au=Tell%2C+Grethe+S&rft.date=2020-11-17&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=142&rft.issue=Suppl_3&rft_id=info:doi/10.1161%2Fcirc.142.suppl_3.15749&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_circ_142_suppl_3_15749 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |